We are live on ! Find out more
XBIO icon

Xenetic Biosciences
XBIO

6 hedge funds and large institutions have $205K invested in Xenetic Biosciences in 2020 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more capital invested

Capital invested by funds: $187K → $205K (+$18K)

0.08% less ownership

Funds ownership: 0.4% → 0.32% (-0.08%)

25% less funds holding

Funds holding: 8 → 6 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
6
Holders Change
-2
Holders Change %
-25%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$8.62K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$45K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$177K +$8.62K +908 +6%
Royal Bank of Canada
2
Royal Bank of Canada
Ontario, Canada
$28K – – –
RE
3
RBC Europe
United Kingdom
$108 – – –
SM
4
Sabby Management
Florida
– -$45K -6,052 Closed

XBIO Hedge Fund Activity: Q2 2020 in Review

6 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Xenetic Biosciences (XBIO) for Q2 2020, worth a combined $205K — up 9.6% from $187K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of XBIO and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Renaissance Technologies, adding an estimated $8.62K. The largest seller was Sabby Management, exiting entirely with an estimated $45K sold.

  • 6 institutional investors held Xenetic Biosciences (XBIO) as of Q2 2020, down from 8 in Q1 2020.
  • Funds reported $205K of Xenetic Biosciences stock for Q2 2020, up 9.6% quarter-over-quarter.
  • 0 funds opened new Xenetic Biosciences positions in Q2 2020 and 2 closed out, a net change of -2 holders.
  • The largest Xenetic Biosciences buyer in Q2 2020 was Renaissance Technologies, an estimated $8.62K added.
  • The largest Xenetic Biosciences seller in Q2 2020 was Sabby Management, an estimated $45K sold.

Based on aggregated 13F filings for Q2 2020.